These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22586584)

  • 21. Dendritic cell-directed CTLA-4 engagement during pancreatic beta cell antigen presentation delays type 1 diabetes.
    Karumuthil-Melethil S; Perez N; Li R; Prabhakar BS; Holterman MJ; Vasu C
    J Immunol; 2010 Jun; 184(12):6695-708. PubMed ID: 20483724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing patterns of cell surface mono (ADP-ribosyl) transferase antigen ART2.2 on resting versus cytopathically-activated T cells in NOD/Lt mice.
    Ablamunits V; Bridgett M; Duffy T; Haag F; Nissen M; Koch-Nolte F; Leiter H
    Diabetologia; 2001 Jul; 44(7):848-58. PubMed ID: 11508269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
    Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice.
    Lin MS; Tse HM; Delmastro MM; Bertera S; Wong CT; Lakomy R; He J; Sklavos MM; Coudriet GM; Pietropaolo M; Trucco MM; Piganelli JD
    Immunol Res; 2011 Aug; 50(2-3):213-20. PubMed ID: 21717080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
    Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
    ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor 4 inhibition prevents autoimmune diabetes in NOD mice.
    Alibashe-Ahmed M; Brioudes E; Reith W; Bosco D; Berney T
    Sci Rep; 2019 Dec; 9(1):19350. PubMed ID: 31852918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
    Jaakkola I; Jalkanen S; Hänninen A
    Eur J Immunol; 2003 Dec; 33(12):3255-64. PubMed ID: 14635033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.
    Grosso JF; Kelleher CC; Harris TJ; Maris CH; Hipkiss EL; De Marzo A; Anders R; Netto G; Getnet D; Bruno TC; Goldberg MV; Pardoll DM; Drake CG
    J Clin Invest; 2007 Nov; 117(11):3383-92. PubMed ID: 17932562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance.
    Gregg RK; Bell JJ; Lee HH; Jain R; Schoenleber SJ; Divekar R; Zaghouani H
    J Immunol; 2005 Jan; 174(2):662-70. PubMed ID: 15634884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-γ Limits Diabetogenic CD8
    Driver JP; Racine JJ; Ye C; Lamont DJ; Newby BN; Leeth CM; Chapman HD; Brusko TM; Chen YG; Mathews CE; Serreze DV
    Diabetes; 2017 Mar; 66(3):710-721. PubMed ID: 27920091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3.
    Bettini M; Szymczak-Workman AL; Forbes K; Castellaw AH; Selby M; Pan X; Drake CG; Korman AJ; Vignali DA
    J Immunol; 2011 Oct; 187(7):3493-8. PubMed ID: 21873518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens.
    El Mir S; Triebel F
    J Immunol; 2000 Jun; 164(11):5583-9. PubMed ID: 10820232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.
    Madec AM; Mallone R; Afonso G; Abou Mrad E; Mesnier A; Eljaafari A; Thivolet C
    Diabetologia; 2009 Jul; 52(7):1391-9. PubMed ID: 19421731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha.
    Cantor J; Haskins K
    J Immunol; 2005 Dec; 175(11):7738-45. PubMed ID: 16301684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesis.
    Atlan-Gepner C; Hermitte L; Janand-Delenne B; Naquet P; Vialettes B
    Diabetes Metab; 1997 Nov; 23(5):386-94. PubMed ID: 9416430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells.
    Rosso O; Piazza T; Bongarzone I; Rossello A; Mezzanzanica D; Canevari S; Orengo AM; Puppo A; Ferrini S; Fabbi M
    Mol Cancer Res; 2007 Dec; 5(12):1246-53. PubMed ID: 18171982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.